Shortening the Alzheimer’s disease assessment scale cognitive subscale
Abstract Background A short yet reliable cognitive measure is needed that separates treatment and placebo for treatment trials for Alzheimer’s disease. Hence, we aimed to shorten the Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) and test its use as an efficacy measure. Metho...
Main Authors: | Stephen Z. Levine, Yair Goldberg, Anat Rotstein, Myrto Samara, Kazufumi Yoshida, Andrea Cipriani, Takeshi Iwatsubo, Stefan Leucht, Toshiaki A. Furukawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2024-01-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933824000142/type/journal_article |
Similar Items
-
Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
by: Stephen Z. Levine, et al.
Published: (2021-01-01) -
Developing a shortened version of the dementia knowledge assessment scale (DKAS-TC) with a sample in Taiwan: an item response theory approach
by: Su-Pin Hung, et al.
Published: (2022-11-01) -
Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
by: Levine, SZ, et al.
Published: (2022) -
Alzheimer's disease severity, objectively determined and measured
by: Alden L. Gross, et al.
Published: (2016-01-01) -
The cognitive subscale of the "Alzheimer's Disease Assessment Scale" in a Brazilian sample
by: R.R. Schultz, et al.
Published: (2001-10-01)